ARTICLE | Clinical News
SRL172: Phase II
March 19, 2001 8:00 AM UTC
University of Manchester researchers published in the Journal of Allergy and Clinical Immunology that intradermal administration of SRL 172 in 41 patients aged 5-18 years with moderate to severe atopi...